Siegfried AG
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Switzerland
- Registered address
- Untere Bruhlstrasse 4, Zofingen, Argovia 4800, Switzerland (CHE)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3002808158 · DUNS 482824026
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-02-14
- NAIDrug Quality Assurance2019-06-14
- VAIDrug Quality Assurance2017-01-27
- NAIDrug Quality Assurance2014-02-06
- VAIDrug Quality Assurance2012-06-21
- NAIDrug Quality Assurance2010-07-29
Drugs this plant is listed as making
4 distinct drugs across 8 products name this site in their FDA label.
- buprenorphine hydrochloride, naloxone hydrochlorideIndivior Inc.
- carbacholAlcon Laboratories, Inc.
- Fluorescein Sodium and Proparacaine HydrochlorideAltaire Pharmaceuticals Inc.
- solriamfetolAxsome Therapeutics, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.